Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528417) titled 'Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)' on April 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
Primary Sponsor: University of Manitoba
Condition:
Myeldysplastic Syndrome (MDS)
MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)
Acute Myeloid Leukemia
Intervention:
Drug: Levofloxacin
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: June 1, 2026
Target Sample Size: 75
Countries of Recruitment:
C...